Life Sciences and Health

With a highly specialized team and consolidated experience in the areas of administrative and regulatory law, we advise our clients in regulatory issues related to life sciences and product regulation.

Our team provides services to investors, pharmaceutical and medical device companies, hospitals, healthcare providers and health techs, health insurance carriers, manufacturers, distributors, and importers of cosmetics and personal care products, agricultural products, food and beverages, genetically modified products, fertilizers and pesticides, and tobacco products.

We work on cases involving the Ministry of Health, National Supplementary Health Agency (ANS), National Health Surveillance Agency (ANVISA), state and municipal health surveillance agencies, National Consumer Secretariat (SENACON), PROCONs, National Institute of Metrology, Quality and Technology (INMETRO), State and Federal Public Prosecution Service, Brazilian Federal Police, Brazilian Army, Ministry of Agriculture, Livestock and Supply (MAPA), among other entities.

Our services include:

Investor relations: we advise companies in mergers and acquisitions, asset sales, due diligences involving assets in the sector.

Government licenses and permits: we assist companies in proceedings related to obtaining permits, authorizations, and licenses to operate, and to register regulated products.

Regulatory consulting: we advise companies on regulatory issues involving registration, licensing, marketing, advertising, packaging, promotions, as well as public consultation/hearing procedures.

Bidding and administrative contracts: we advise companies in bidding and execution of administrative contracts.

Litigation: we represent companies in administrative and judicial proceedings.

Recall: We represent and advise companies in recall procedures, before ANVISA and SENACON.

Compliance: we assist companies in compliance investigations.

The Life Sciences and Health department acts in close connection with the other areas of the firm, including collaboration with the following:

Regulation, Competition, and Infrastructure

Technology and Intellectual Property

Corporate, M&A and Capital Markets